o2h Ventures App app for iPhone and iPad
Developer: Oxygen Healthcare Research Private Limited
First release : 22 Sep 2019
App size: 22.28 Mb
Invest in EIS conveniently and securely with the o2h Ventures App
o2h Ventures has launched the first-of-a-kind investment app for its recently launched the o2h Therapeutics and AI fund which is Britains first ever EIS fund focused on biotech therapeutics and AI.
The o2h Ventures interactive app will make it easy for both new and existing investors to invest into the fund on the go. Just few clicks - few steps to cover - and you are welcome on-board!
The app has easy to register and easy to invest features weeding out all the traditional and monotonous procedures followed until now to invest in an EIS or SEIS fund in the UK.
Scan and Go:
The app’s innovative features including scanning driver license and integrated google maps harness the power of machine learning and AI to extract necessary data autonomously - making it hassle-free for investors to fill up the not so enticing investment forms in just-few-minutes.
Top-Up in Minutes:
‘Top-Up’ is another enticing and innovative feature of the app which is an outcome of fund manager’s years of experience in EIS investing. With this feature, an existing investor is at liberty to add additional funds to his/her current subscription without having to reinvent the wheel.
Process:
Register - If you are a High Net Worth or Sophisticated investor and wish to invest into the fund, you will need to register and self certify by simply clicking on the ‘register’ button which will redirect you to the registration page.
Login- If you are an existing investor and have registered before through the app, all you need to do is login using ‘username and Password’.
(o2h Ventures Limited is regulated and authorised by the Financial Conduct Authority (FRN 812245). Capital at risk, only suitable for high net worth and sophisticated investors.)
Customer Support:
Should you have any questions regarding the o2h Ventures App, please contact us for support at [email protected] or to invest into the fund please reach us at [email protected]